Lymphangiosarcoma: Clinical Trials

2 trials for Lymphangiosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Unknown 1

Follow Lymphangiosarcoma: new trials by email Literature Review of Lymphangiosarcoma trials Research Report on Lymphangiosarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall
Sequential chemotherapy - 3 courses of AI, Hypofractionated radiotherapy - Sarcoma, Fibrosarcoma
Phase 2UnknownMaria Sklodowska-Curie National Research Institute of Oncology462017-02-112021-01-22
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
belinostat, 5-Fluorouracil (5-FU) - Tumor
Phase 1CompletedValerio Therapeutics352005-09-012015-07-08

Narrower conditions

Fibrosarcoma (2)  ·  Histiocytoma, Malignant Fibrous (2)  ·  Leiomyosarcoma (2)  ·  Liposarcoma (2)  ·  Myosarcoma (2)  ·  Sarcoma (2)  ·  Adenosarcoma (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Small Cell (1)  ·  Carcinosarcoma (1)  ·  Chondrosarcoma (1)  ·  Colorectal Neoplasms (1)

Broader conditions

Histiocytoma (2)  ·  Neoplasm, Lymphatic Tissue (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Adipose Tissue (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Neoplasms, Fibrous Tissue (2)  ·  Neoplasms, Muscle Tissue (2)  ·  Adenoma (1)  ·  Adnexal Diseases (1)  ·  Breast Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)

Interventions

Fluorouracil (1)  ·  Radiation Dose Hypofractionation (1)  ·  belinostat (1)

Sponsors

Maria Sklodowska-Curie National Research Institute of Oncology (1)  ·  Valerio Therapeutics (1)

Countries

Poland (1)  ·  United States (1)

Results publications

PMID 42194972